Show simple item record

Glycosaminoglycans and Proteoglycans

dc.contributor.authorBarbara Mulloy (Ed.)*
dc.date.accessioned2021-02-11T14:43:30Z
dc.date.available2021-02-11T14:43:30Z
dc.date.issued2018*
dc.date.submitted2018-07-04 13:46:48*
dc.identifier27255*
dc.identifier.urihttps://directory.doabooks.org/handle/20.500.12854/48726
dc.description.abstractProteoglycans (PGs) are glycoconjugates in which a protein or peptide core is substituted with polysaccharide chains known as glycosaminoglycans (GAGs). The GAG sidechains carry a significant proportion of the functionality of PGs, interacting with many proteins to form structural units in the extracellular matrix and to modulate the transport and signalling of small proteins acting as morphogens, growth factors and cytokines. Purified GAGs such as heparin and hyaluronan are in common use as therapeutic agents, with many more PG-based natural products, synthetic and semi-synthetic mimetics on the way; in addition, potential therapeutic strategies involving PG/GAG biosynthesis and degradation as targets are currently in development.*
dc.languageEnglish*
dc.subjectRM1-950*
dc.subject.classificationthema EDItEUR::M Medicine and Nursing::MK Medical specialties, branches of medicine::MKG Pharmacologyen_US
dc.subject.otherheparin*
dc.subject.otherhyauronan*
dc.subject.otherkeratan*
dc.subject.otherchondroitin*
dc.subject.otherglycosaminoglycan*
dc.subject.otherdermatan*
dc.subject.otherproteoglycan*
dc.titleGlycosaminoglycans and Proteoglycans*
dc.typebook
oapen.relation.isPublishedBy46cabcaa-dd94-4bfe-87b4-55023c1b36d0*
oapen.relation.isbn9783038428367*
oapen.relation.isbn9783038428350*
oapen.pagesXVI, 230*
oapen.edition1st*


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record

https://creativecommons.org/licenses/by-nc-nd/4.0/
Except where otherwise noted, this item's license is described as https://creativecommons.org/licenses/by-nc-nd/4.0/